Request For Applications (RFAs)
The NINR invites grant proposals in the following defined areas of research. RFAs are one-time opportunities with one submission date. The RFA is closed after its expiration date. All RFAs, active or inactive may be viewed in current or previous issues of the NIH Guide for Grants and Contracts
Displaying 1 - 13 of 13
Title: Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required)
Announcement Number: RFA-OD-20-003Release Date: Friday, December 13, 2019
Expiration Date: Thursday, November 4, 2021
Activity Code: R61/R33
Title: INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed)
Announcement Number: RFA-OD-20-004Release Date: Friday, December 13, 2019
Expiration Date: Thursday, November 4, 2021
Activity Code: R21
Title: Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required)
Announcement Number: RFA-OD-20-003Release Date: Friday, December 13, 2019
Expiration Date: Thursday, November 4, 2021
Activity Code: R61/R33
Title: INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed)
Announcement Number: RFA-OD-20-004Release Date: Friday, December 13, 2019
Expiration Date: Thursday, November 4, 2021
Activity Code: R21
Title: HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required)
Announcement Number: RFA-NS-20-010Release Date: Friday, October 4, 2019
Expiration Date: Friday, September 9, 2022
Activity Code: R43/R44
Title: HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed)
Announcement Number: RFA-NS-20-011Release Date: Friday, October 4, 2019
Expiration Date: Friday, September 9, 2022
Activity Code: R43/R44
Title: HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed)
Announcement Number: RFA-NS-20-011Release Date: Friday, October 4, 2019
Expiration Date: Friday, September 9, 2022
Activity Code: R43/R44
Title: HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required)
Announcement Number: RFA-NS-20-008Release Date: Friday, October 4, 2019
Expiration Date: Friday, September 9, 2022
Activity Code: R41/R42
Title: HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)
Announcement Number: RFA-NS-20-009Release Date: Friday, October 4, 2019
Expiration Date: Friday, September 9, 2022
Activity Code: R41/R42
Title: The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional)
Announcement Number: RFA-OD-19-029Release Date: Friday, September 27, 2019
Expiration Date: Saturday, November 27, 2021
Activity Code: R01
Title: HEAL Initiative: Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional)
Announcement Number: RFA-NS-19-016Release Date: Monday, December 10, 2018
Expiration Date: Tuesday, February 23, 2021
Activity Code: UG3/UH3
Title: HEAL Initiative: Translational Devices to Treat Pain (U44 Clinical Trial Optional)
Announcement Number: RFA-NS-19-017Release Date: Monday, December 10, 2018
Expiration Date: Tuesday, February 23, 2021
Activity Code: U44
Title: HEAL Initiative: Clinical Devices to Treat Pain (UH3 Clinical Trial Optional)
Announcement Number: RFA-NS-19-018Release Date: Monday, December 10, 2018
Expiration Date: Tuesday, February 23, 2021
Activity Code: UH3
Back to Top